Halozyme Therapeutics Shares Up 31.1% Since SmarTrend's Buy Recommendation (HALO)

SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on March 1st, 2016 at $9.07. In approximately 2 months, Halozyme Therapeutics has returned 31.11% as of today's recent price of...